-
Glenmark receives ANDA approval for steroidal drug from US FDA
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the US FDA for Estradiol Vaginal Inserts USP, 10 mcg, the generic version of Vag...
2018-10-17 13:47 -
Glenmark Pharmaceuticals inducted into the Dow Jones Sustainability Indices
The evaluation included 24 long-term economic, environmental and social criteria. Glenmark secured high scores for marketing practices, product qualit...
2018-10-17 13:46 -
NeuroVive Receives KL1333 Clinical Trial Regulatory Approval
NeuroVive Pharmaceutical has received approval of its clinical trial application concerning a planned phase I KL1333 study in patients and healthy vol...
2018-10-12 15:26 -
IAVI Announces Clinical Trial of HIV Vaccine Candidate
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designe...
2018-10-12 15:25 -
Nanoreactors to synthesise organic substances
A RUDN University chemist developed a new type of photocatalysts – nanostructures from titanium dioxide. Hollow nanocubes with ultra-thin walls act l...
2018-10-12 15:10 -
New Data Released on Stelara for Ulcerative Colitis
In addition, both doses of Stelara resulted in statistically significant improvements in the Inflammatory Bowel Disease Questionnaire (IBDQ), a health...
2018-10-12 15:03 -
Ionis Enters Collaboration with Partner to Develop IONIS-FB-LRx
Ionis announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. This collaboration will leve...
2018-10-12 15:02 -
Janssen submits MAA to EMA for esketamine nasal spray
Johnson & Johnson’s Janssen Pharmaceutical Companies has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA)...
2018-10-12 14:58 -
Pharmaxis Releases Positive Results of for LOXL2 Trial
Pharmaxis announced positive results from the Phase 1 clinical trial for the first of its Lysyl Oxidase Like 2 (LOXL2) inhibitor compounds being devel...
2018-10-12 14:56 -
Bristol-Myers Squibb, Compugen Announce Clinical Collaboration
Under the terms of the share purchase agreement, Bristol-Myers Squibb will make a $12 million investment in Compugen comprised of 2,424,243 shares of ...
2018-10-12 14:52
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- The Truth Behind the US-China ... Jun 30, 2025
Related Products
Related Producers
